In brain tumors, specifically in gliomagenesis, it was found that miRNA-221/222 acts as an oncogenic miRNA by targeting Cx43, reducing its expression, and promoting glioma growth [71]. The gene discussed is GJA1; the disease is central nervous system cancer.